Next Article in Journal
Spectroscopic and Kinetic Characterization of Peroxidase-Like π-Cation Radical Pinch-Porphyrin-Iron(III) Reaction Intermediate Models of Peroxidase Enzymes
Next Article in Special Issue
Layered Double Hydroxide as a Vehicle to Increase Toxicity of Gallate Ions against Adenocarcinoma Cells
Previous Article in Journal
Chemical Synthesis of Deoxynivalenol-3-β-d-[13C6]-glucoside and Application in Stable Isotope Dilution Assays
Previous Article in Special Issue
Optimization of Preparation Conditions for Lysozyme Nanoliposomes Using Response Surface Methodology and Evaluation of Their Stability
Open AccessReview

Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes

Department of Biotechnology, East-West College of Science, Bangalore-560091, Karnataka, India
Department of Crop Science, Faculty of Agriculture, Universiti Putra Malaysia, Serdang, Selangor, Darul Ehsan 43400, Malaysia
Authors to whom correspondence should be addressed.
Academic Editor: Didier Astruc
Molecules 2016, 21(7), 836;
Received: 15 March 2016 / Revised: 17 June 2016 / Accepted: 20 June 2016 / Published: 27 June 2016
(This article belongs to the Collection Nanomedicine)
Antimicrobial substances may be synthetic, semisynthetic, or of natural origin (i.e., from plants and animals). Antimicrobials are considered “miracle drugs” and can determine if an infected patient/animal recovers or dies. However, the misuse of antimicrobials has led to the development of multi-drug-resistant bacteria, which is one of the greatest challenges for healthcare practitioners and is a significant global threat. The major concern with the development of antimicrobial resistance is the spread of resistant organisms. The replacement of conventional antimicrobials by new technology to counteract antimicrobial resistance is ongoing. Nanotechnology-driven innovations provide hope for patients and practitioners in overcoming the problem of drug resistance. Nanomaterials have tremendous potential in both the medical and veterinary fields. Several nanostructures comprising metallic particles have been developed to counteract microbial pathogens. The effectiveness of nanoparticles (NPs) depends on the interaction between the microorganism and the NPs. The development of effective nanomaterials requires in-depth knowledge of the physicochemical properties of NPs and the biological aspects of microorganisms. However, the risks associated with using NPs in healthcare need to be addressed. The present review highlights the antimicrobial effects of various nanomaterials and their potential advantages, drawbacks, or side effects. In addition, this comprehensive information may be useful in the discovery of broad-spectrum antimicrobial drugs for use against multi-drug-resistant microbial pathogens in the near future. View Full-Text
Keywords: nanoparticles; drug resistance; antimicrobial; mode of action; synthesis; silver; metal oxide; pathogens; antibiotics; medicine nanoparticles; drug resistance; antimicrobial; mode of action; synthesis; silver; metal oxide; pathogens; antibiotics; medicine
Show Figures

Graphical abstract

MDPI and ACS Style

Rudramurthy, G.R.; Swamy, M.K.; Sinniah, U.R.; Ghasemzadeh, A. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes. Molecules 2016, 21, 836.

AMA Style

Rudramurthy GR, Swamy MK, Sinniah UR, Ghasemzadeh A. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes. Molecules. 2016; 21(7):836.

Chicago/Turabian Style

Rudramurthy, Gudepalya R.; Swamy, Mallappa K.; Sinniah, Uma R.; Ghasemzadeh, Ali. 2016. "Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes" Molecules 21, no. 7: 836.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop